€100,000 in grant funds
The European Pharmaceutical Market is projected to grow from €169 Billion in 2015 to €206 Billion in 2022. (source). One of the 20th century's most innovative pharmaceutical researchers - Dr. Paul Janssen - first established Janssen Pharmaceutica N.V. in Europe more than six decades ago and lay the foundation for the discovery and development of more than 80 new medicines. That Belgian biotech industry alone funneled €3.4 billion into research and development in 2016, a staggering increase of 123% compared to 10 years earlier.
In celebration of and collaboration with these strides in human healthcare, Johnson & Johnson Innovation Limited and Johnson & Johnson Innovation, JLABS have launched the European Innovation QuickFire Challenge.. The innovator with the best idea, technology, or solution that improves human healthcare and impacts the European ecosystem will receive up to €100,000 in grants as well as a voucher for one year of residency at an available JLABS locations, including a laboratory bench, workstation and access to the global JLABS community.
JLABS is continuing to expand towards a truly global open innovation ecosystem by nurturing breakthrough science at a growing network of JLABS locations, including upcoming launches spanning from New York City to Shanghai. This unique model provides entrepreneurs with access to state-of-the-art infrastructure, expertise, and funding opportunities in a no-strings-attached environment.